🇯🇵 Verquvo in Japan

PMDA authorised Verquvo on 23 June 2021

Marketing authorisations

PMDA — authorised 23 June 2021

  • Marketing authorisation holder: BAYER YAKUHIN, Ltd.
  • Status: approved

Verquvo in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in Japan

Frequently asked questions

Is Verquvo approved in Japan?

Yes. PMDA authorised it on 23 June 2021; PMDA has authorised it.

Who is the marketing authorisation holder for Verquvo in Japan?

BAYER YAKUHIN, Ltd. holds the Japanese marketing authorisation.